.Pharmacolibrary.Drugs.L_AntineoplasticAndImmunomodulatingAgents.L02A_HormonesAndRelatedAgents.L02AE02_Leuprorelin.Leuprorelin

Information

name:Leuprorelin
ATC code:L02AE02
route:subcutaneous
n-compartments2

Leuprorelin (leuprolide acetate) is a synthetic gonadotropin-releasing hormone (GnRH) agonist, primarily used for the treatment of hormone-responsive cancers such as prostate cancer, endometriosis, uterine fibroids, and precocious puberty. It is approved and widely used in clinical practice today.

Pharmacokinetics

Pharmacokinetic parameters reported in adult males with advanced prostate cancer following a single subcutaneous 1 mg dose.

References

    Revisions

    Generated at 2025-07-21T18:21:10Z by OpenModelicaOpenModelica 1.25.1 using GenerateDoc.mos